Showing results (241-250 of 263) with videos related to
Sort By:
Pageof 27
The Journal of Biological Chemistry|December 24, 2011
Identification of mono- and disulfated N-acetyl-lactosaminyl Oligosaccharide structures as epitopes specifically recognized by humanized monoclonal antibody HMOCC-1 raised against ovarian cancerToshiaki K Shibata, Fumiko Matsumura, Ping Wang, et al.Cell Chemical Biology|February 5, 2020
Small Molecule Inhibition of CPS1 Activity through an Allosteric PocketShihua Yao, Tuong-Vi Nguyen, Alan Rolfe, et al.Molecular Cancer Therapeutics|March 21, 2022
Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non-Muscle Invasive Murine Bladder CancerKuan-Chun Huang, Dinesh Chanda, Shannon McGrath, et al.Journal for Immunotherapy of Cancer|June 20, 2020
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancersDavid S Hong, Aparna Parikh, Geoffrey I Shapiro, et al.Journal of Clinical Medicine|September 28, 2021
Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating FactorYosuke Dotsu, Hiroyuki Yamaguchi, Minoru Fukuda, et al.JTO Clinical and Research Reports|December 4, 2023
A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)Kazushige Wakuda, Hiroyuki Yamaguchi, Hirotsugu Kenmotsu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 22, 2021
A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)Hiroyuki Yamaguchi, Kazushige Wakuda, Minoru Fukuda, et al.Thoracic Cancer|July 17, 2019
Phase II study of nedaplatin and amrubicin as first-line treatment for advanced squamous cell lung cancerHirokazu Taniguchi, Hiroyuki Yamaguchi, Yosuke Dotsu, et al.Translational Lung Cancer Research|May 17, 2023
Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targetsMidori Shimada, Hirokazu Taniguchi, Hiroyuki Yamaguchi, et al.Translational Lung Cancer Research|November 7, 2024
Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study)Shinnosuke Takemoto, Minoru Fukuda, Ryosuke Ogata, et al.Pageof 27